Vogt Frederick Ginsider trades
In SEC Form 4 filings, Vogt Frederick G is listed as Interim CEO & General Counsel of Iovance Biotherapeutics, Inc. (IOVA). Vogt Frederick G reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 10.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | Interim CEO & General Counsel | 6 | Sep 10 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | Sep 8 | Sep 10 | M | 15,626 | $0.00 | $0 | 602,085 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 8 | Sep 10 | F | 6,638 | $8.70 | $57,751 | 595,447 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 8 | Sep 10 | M · derivative | 15,626 | $0.00 | $0 | 93,756 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 1 | Sep 3 | M | 41,669 | $0.00 | $0 | 604,161 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 1 | Sep 3 | F | 17,702 | $8.28 | $146,573 | 586,459 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 41,669 | $0.00 | $0 | 83,338 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.